Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Change in Receivables (2016 - 2018)

InflaRx's Change in Receivables history spans 3 years, with the latest figure at $81493.4 for Q4 2018.

  • On a quarterly basis, Change in Receivables fell 93.33% to $81493.4 in Q4 2018 year-over-year; TTM through Dec 2018 was -$1.0 million, a 133.86% decrease, with the full-year FY2021 number at -$8.1 million, down 357.23% from a year prior.
  • Change in Receivables hit $81493.4 in Q4 2018 for InflaRx, up from -$807211.6 in the prior quarter.
  • Over the last five years, Change in Receivables for IFRX hit a ceiling of $1.2 million in Q4 2017 and a floor of -$966503.9 in Q2 2017.
  • Historically, Change in Receivables has averaged -$181414.3 across 3 years, with a median of -$137125.0 in 2016.
  • Biggest five-year swings in Change in Receivables: skyrocketed 991.29% in 2017 and later plummeted 93.33% in 2018.
  • Tracing IFRX's Change in Receivables over 3 years: stood at -$137125.0 in 2016, then skyrocketed by 991.29% to $1.2 million in 2017, then plummeted by 93.33% to $81493.4 in 2018.
  • Business Quant data shows Change in Receivables for IFRX at $81493.4 in Q4 2018, -$807211.6 in Q3 2018, and -$374741.5 in Q2 2018.